Skip to content
Vitravene preservative free, Vitravene(fomivirsen)
Vitravene (fomivirsen) is an oligonucleotide pharmaceutical. Fomivirsen was first approved as Vitravene preservative free on 1998-08-26. It is used to treat cytomegalovirus retinitis in the USA. It has been approved in Europe to treat cytomegalovirus retinitis and HIV infections.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
eye diseasesD005128
urogenital diseasesD000091642
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Fomivirsen sodium
Tradename
Company
Number
Date
Products
VITRAVENE PRESERVATIVE FREENovartisN-020961 DISCN1998-08-26
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
cytomegalovirus retinitisEFO_1001302D017726
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01A: Antiinfective ophthalmologics
S01AD: Antivirals, ophthalmologic
S01AD08: Fomivirsen
HCPCS
Code
Description
J1452
Injection, fomivirsen sodium, intraocular, 1.65 mg
Clinical
Clinical Trials
62 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Obsessive-compulsive disorderD009771EFO_0004242F4212429
SchizophreniaD012559EFO_0000692F201124
Anxiety disordersD001008EFO_0006788F41.12114
Depressive disorderD003866EFO_1002014F32.A123
Major depressive disorderD003865EFO_0003761F2233
Mental disordersD001523EFO_0000677F91.911
Treatment outcomeD01689611
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.1448
DepressionD003863F33.91135
CoronavirusD017934112
Separation anxietyD001010EFO_1001916112
Social phobiaD000072861EFO_1001917F40.1112
Severe acute respiratory syndrome-related coronavirusD045473NCBITaxon_22785911
DementiaD003704F0311
Psychophysiologic disordersD011602F45.911
Autistic disorderD001321EFO_0003758F84.011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronavirus infectionsD018352EFO_0007224B34.211
Sars-cov-2D00008640211
Olfaction disordersD000857R43.011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients1313
Breast neoplasmsD001943EFO_0003869C5011
Drug interactionsD00434711
Atopic dermatitisD003876EFO_0000274L2011
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.8111
Weight gainD015430HP_000432411
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825G31.8422
Bipolar disorderD001714EFO_0000289F30.911
Wounds and injuriesD014947T14.811
PainD010146EFO_0003843R5211
Substance-related disordersD019966EFO_0003890F1311
Chronic diseaseD00290811
Brain injuriesD001930S06.911
Alcohol-related disordersD019973F1011
Post-traumatic stress disordersD013313EFO_0001358F43.111
Suicidal ideationD059020EFO_0004320R45.85111
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFOMIVIRSEN
INNfomivirsen
Description
Fomivirsen (brand name Vitravene) is an antisense antiviral drug that was used in the treatment of cytomegalovirus retinitis (CMV) in immunocompromised patients, including those with AIDS. It was administered via intraocular injection.
Classification
Oligonucleotide
Drug classantisense oligonucleotides: antivirals; antivirals
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID160369-77-7
RxCUI314633
ChEMBL IDCHEMBL1201688
ChEBI ID
PubChem CID71587550
DrugBankDB06759
UNII IDQX5LK7YCHV (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 659 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3,231 adverse events reported
View more details